Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

ClinicalTrials.gov ID: NCT00969150

Public ClinicalTrials.gov record NCT00969150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.

Study identification

NCT ID
NCT00969150
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
362 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Not listed
Last update posted
Oct 25, 2013

Started 2009

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Forest Investigative Site Scottsdale Arizona 85254 —
Forest Investigative Site Encino California 91316 —
Forest Investigative Site Los Alamitos California 90720 —
Forest Investigative Site Oceanside California 92056 —
Forest Investigative Site Denver Colorado 80204 —
Forest Investigative Site Denver Colorado 80239 —
Forest Investigative Site Jacksonville Florida 32216 —
Forest Investigative Site Orlando Florida 32806 —
Forest Investigative Site Chicago Illinois 60634 —
Forest Investigative Site Wichita Kansas 67206 —
Forest Investigative Site Glen Burnie Maryland 21061 —
Forest Investigative Site Fall River Massachusetts 02721 —
Forest Investigative Site East Lansing Michigan 48824 —
Forest Investigative Site Cherry Hill New Jersey 08002 —
Forest Investigative Site Brooklyn New York 11235 —
Forest Investigative Site New York New York 10021 —
Forest Investigative Site Staten Island New York 10312 —
Forest Investigative Site 013 Canton Ohio 44718 —
Forest Investigative Site Dayton Ohio 45417 —
Forest Investigative Site Portland Oregon 97210 —
Forest Investigative Site Philadelphia Pennsylvania 19107 —
Forest Investigative Site Lincoln Rhode Island 02865 —
Forest Investigative Site Woodstock Vermont 05091 —
Forest Investigative Site Bellevue Washington 98007 —
Forest Investigative Site Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00969150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2013 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00969150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →